These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7839940)

  • 1. Tetanus antibodies at booking in a Nigerian obstetric population.
    Okafor GO; Gini PC
    Afr J Med Med Sci; 1994 Mar; 23(1):19-22. PubMed ID: 7839940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetanus immunization status among women of childbearing age in Turkey.
    Esen B; Kurtoglu D; Coplu N; Gozalan A; Miyamura K; Ishida S; Akin L
    Jpn J Infect Dis; 2007 May; 60(2-3):92-6. PubMed ID: 17515639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental transfer of tetanus toxoid antibodies in Nigerian mothers.
    Hood N; Chan MC; Maxwell SM; Familusi JB; Hart CA
    Ann Trop Paediatr; 1994; 14(3):179-82. PubMed ID: 7825989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serological study carried out in Cambodia during a tetanus vaccination in adults].
    Schlumberger M; Yvonnet B; Que HV; Chhem DB; Saliou P; Le Tu TC; Glaziou P
    Bull Soc Pathol Exot; 2008 Feb; 101(1):36-42. PubMed ID: 18432006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response to varied timing and spacing of tetanus toxoid administration in pregnancy.
    Gini PC; Okafor GO
    East Afr Med J; 1992 Mar; 69(3):157-61. PubMed ID: 1505406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with missed opportunities to immunise with tetanus toxoid at a tertiary health institution in Nigeria.
    Edet EE; Ikpeme BM; Ndifon WO; Oyo-Ita AE
    Cent Afr J Med; 1998 Aug; 44(8):199-202. PubMed ID: 10101419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
    Al Aswad IH; Shubair ME
    East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetanus IgG antibody levels in children aged 12 to 47 months in Turkey.
    Yildirim RC; Yilmaz N; Yildirim U; Aksakal FN
    Am J Infect Control; 2001 Apr; 29(2):120-3. PubMed ID: 11287881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based seroepidemiology of tetanus in three selected provinces in Turkey.
    Kurtoglu D; Gozalan A; Coplu N; Miyamura K; Morita M; Esen B; Akin L
    Jpn J Infect Dis; 2004 Feb; 57(1):10-6. PubMed ID: 14985630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunity against tetanus 3 years after revaccination].
    Bozović M; Pavlović V
    Med Pregl; 1991; 44(1-2):77-8. PubMed ID: 1870472
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistence of antibodies against tetanus upon revaccination.
    Matousková I; Matlerová S; Janoutová G; Janout V
    Cent Eur J Public Health; 2005 Jun; 13(2):99-102. PubMed ID: 15969459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of specific immune response to unadsorbed concentrated tetanus vaccine administered by intradermal route to non-immunized persons in the last ten years.
    Dimache G; Stoean C; Durbacă S; Croitoru M; Ionescu M; Nedelcu IN; Corbu I
    Arch Roum Pathol Exp Microbiol; 1990; 49(1):51-62. PubMed ID: 2101203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased level of tetanus antibody twenty one years after a booster dose of tetanus vaccine].
    Geraldes F; Queirós L; Santos MA
    Acta Med Port; 2004; 17(2):183-6. PubMed ID: 15921651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The tetanus antibodies titer alterations evaluated by means of indirect hemagglutinin test (HAp) after specific and nonspecific stimulation (author's transl)].
    Wesierska-Gadek J; Wazewska-Czyzewska M; Romanowski T; Reiss J
    Przegl Lek; 1980; 37(11):749-54. PubMed ID: 7005975
    [No Abstract]   [Full Text] [Related]  

  • 15. Missed opportunities for tetanus vaccination in pregnant women, and factors associated with seropositivity.
    Kalaça S; Yalçin M; Simşek Yavuz S
    Public Health; 2004 Jul; 118(5):377-82. PubMed ID: 15178146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The status of maternally acquired tetanus immunity in newborn infants].
    Pietsch M; Schütt KH
    Gesundheitswesen; 1993 Jul; 55(7):364-6. PubMed ID: 8369604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
    Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Process of neonatal tetanus elimination in Nepal.
    Vandelaer J; Partridge J; Suvedi BK
    J Public Health (Oxf); 2009 Dec; 31(4):561-5. PubMed ID: 19443437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune reaction to tetanus in the elderly: what is the duration of vaccine protection?].
    Steger MM; Maczek C; Berger P; Grubeck-Loebenstein B
    Wien Klin Wochenschr; 1997 Oct; 109(19):767-70. PubMed ID: 9441523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetanus toxoid immunization coverage among women in zone 3 of Dhaka city: the challenge of reaching all women of reproductive age in urban Bangladesh.
    Perry H; Weierbach R; Hossain I; Islam R
    Bull World Health Organ; 1998; 76(5):449-57. PubMed ID: 9868835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.